Arizona Drug Firm Insys Makes Synthetic Pot Compound, Spends Big to Defeat Legal Pot

THURSDAY, SEPTEMBER 8, 2016 AT 2:53 P.M.
A Chandler-based drug firm under investigation for its aggressive sales of a lethal painkiller claims that the large donation it made to a group that opposes marijuana legalization was an attempt to protect the public’s safety.
A Chandler-based drug firm under investigation for its aggressive sales of a lethal painkiller claims that the large donation it made to a group that opposes marijuana legalization was an attempt to protect the public’s safety.
A Chandler-based drug firm under investigation for its aggressive sales of a lethal painkiller claims that the large donation it made to a group that opposes marijuana legalization was an attempt to protect the public’s safety.
Prop 205 “fails to protect the safety of Arizona’s citizens, and particularly its children,” according to a statement Insys provided to New Times on Thursday in response to a message left for CEO John Kapoor. “Our stance is consistent with our company’s goals. We strive to develop pharmaceutical products for the supportive care of patients while taking patient safety very seriously. To that end, we believe that all available medicines should meet the clinical standards set by the FDA.”
Yet while Insys holds itself out as the savior of Arizonans’ health, the company is reportedly under investigation in four states, including Arizona, for marketing practices related to Subsys that have allegedly resulted in patient deaths.